DK502078A - Frefmgangsmaade til fremstilling af cephalosporansyrederivater - Google Patents
Frefmgangsmaade til fremstilling af cephalosporansyrederivaterInfo
- Publication number
- DK502078A DK502078A DK502078A DK502078A DK502078A DK 502078 A DK502078 A DK 502078A DK 502078 A DK502078 A DK 502078A DK 502078 A DK502078 A DK 502078A DK 502078 A DK502078 A DK 502078A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- acid derivatives
- cephalosporanic acid
- preparing
- preparing cephalosporanic
- Prior art date
Links
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4735277 | 1977-11-14 | ||
GB1681078 | 1978-04-27 | ||
GB7835436 | 1978-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK502078A true DK502078A (da) | 1979-05-15 |
Family
ID=27257420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK502078A DK502078A (da) | 1977-11-14 | 1978-11-10 | Frefmgangsmaade til fremstilling af cephalosporansyrederivater |
Country Status (15)
Country | Link |
---|---|
US (3) | US4267176A (fr) |
JP (1) | JPS5492987A (fr) |
AT (1) | AT369005B (fr) |
AU (1) | AU523346B2 (fr) |
CA (1) | CA1120923A (fr) |
CH (1) | CH645904A5 (fr) |
DE (1) | DE2848912A1 (fr) |
DK (1) | DK502078A (fr) |
ES (5) | ES475035A1 (fr) |
FR (2) | FR2411839B1 (fr) |
GB (1) | GB2010840B (fr) |
HU (2) | HU183008B (fr) |
IT (1) | IT1192287B (fr) |
NL (1) | NL7811220A (fr) |
SE (2) | SE7811637L (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
DE2818263A1 (de) * | 1978-04-26 | 1979-11-08 | Bayer Ag | Beta-lactamantibiotika |
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
JPS5716886A (en) * | 1980-07-04 | 1982-01-28 | Fujisawa Pharmaceut Co Ltd | Azetidinone bearing oxo group or its salt or hydrate and their preparation |
DE3175156D1 (en) * | 1980-08-29 | 1986-09-25 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
US4577014A (en) * | 1981-09-08 | 1986-03-18 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4402955A (en) * | 1981-10-02 | 1983-09-06 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4379787A (en) * | 1981-10-02 | 1983-04-12 | Eli Lilly And Company | Oximino-substituted cephalosporin compounds |
US4450270A (en) * | 1981-10-02 | 1984-05-22 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4501739A (en) * | 1982-01-19 | 1985-02-26 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4683227A (en) * | 1985-07-09 | 1987-07-28 | Eli Lilly And Company | Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof |
CN102988362B (zh) * | 2005-12-07 | 2014-11-05 | 巴斯利尔药物股份公司 | 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用 |
EA028342B1 (ru) | 2011-09-09 | 2017-11-30 | Мерк Шарп И Доум Корп. | Способы лечения пневмонии |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
NZ700372A (en) | 2013-03-15 | 2016-01-29 | Merck Sharp & Dohme | Ceftolozane antibiotic compositions |
US20140274997A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Cephalosporin pharmaceutical compositions |
EP3043797B1 (fr) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459746A (en) * | 1965-10-04 | 1969-08-05 | Lilly Co Eli | 7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid |
GB1195203A (en) * | 1966-06-24 | 1970-06-17 | Glaxo Lab Ltd | Cephalosporins |
CH527215A (de) * | 1967-04-15 | 1972-08-31 | Fujisawa Pharmaceutical Co | Verfahren zur Herstellung von 3,7-disubstituierten Cephalosporinderivaten |
CH522677A (de) * | 1969-10-10 | 1972-06-30 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure |
FR2068419A1 (en) * | 1969-10-27 | 1971-08-27 | Fujisawa Pharmaceutical Co | Antibacterial cephalosporin compsns |
IL39094A (en) * | 1971-04-21 | 1976-05-31 | Ciba Geigy Ag | 7-(aminopyridiniumacetyl)-3-heterocyclylthiomethyl-cephalosporanic acid derivatives,their manufacture and pharmaceutical compositions containing them |
US4017515A (en) * | 1971-05-14 | 1977-04-12 | Glaxo Laboratories Limited | α-(Etherified oximino) carboxylic acids and acid chlorides |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
US4033950A (en) * | 1971-05-14 | 1977-07-05 | Glaxo Laboratories Limited | 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
US3966717A (en) * | 1971-05-14 | 1976-06-29 | Glaxo Laboratories Limited | 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof |
DE2222791A1 (de) * | 1971-05-19 | 1972-12-07 | Ciba Geigy Ag | Neue Pyridinessigsaeurederivate und Verfahren zu ihrer Herstellung |
BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
BE793724A (fr) * | 1972-01-12 | 1973-07-05 | Smith Kline French Lab | Procede de preparation de cephalosphorines non substituees en position 3, nouvelles cephalosporines obtenues et leur utilisation |
AR208171A1 (es) * | 1972-09-29 | 1976-12-09 | Ciba Geigy Ag | Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico |
GB1390141A (en) * | 1973-01-08 | 1975-04-09 | Ici Ltd | Pyrimidine derivatives and processes for their production |
JPS5932472B2 (ja) * | 1973-03-15 | 1984-08-09 | 藤沢薬品工業株式会社 | 2−アルキル−7−アシルアミノ−2(または3)−セフエム−4−カルボン酸類の製造法 |
JPS4970990A (fr) * | 1973-09-29 | 1974-07-09 | ||
US3968109A (en) * | 1973-11-23 | 1976-07-06 | E. R. Squibb & Sons, Inc. | Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins |
FR2262965A1 (en) * | 1974-03-05 | 1975-10-03 | Delalande Sa | Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity |
US4122259A (en) * | 1974-08-23 | 1978-10-24 | Glaxo Laboratories Limited | 7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids |
JPS604171B2 (ja) * | 1974-12-05 | 1985-02-01 | 久光製薬株式会社 | 新規な2−アニリノピリジン−3−酢酸誘導体の製造法 |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
CA1088049A (fr) * | 1975-06-03 | 1980-10-21 | Takashi Masugi | Procedes d'obtention de derives d'acides alcanamido substitues en 3 et substitues en 7-3-cephem-4 carboxyliques |
US4152433A (en) * | 1976-03-12 | 1979-05-01 | Fujisawa Pharmaceutical Co., Ltd. | 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions |
US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
US4104469A (en) * | 1977-04-15 | 1978-08-01 | Bristol-Myers Company | 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids |
NL7714319A (nl) * | 1976-12-27 | 1978-06-29 | Fujisawa Pharmaceutical Co | Cefalosporineverbindingen en werkwijzen om deze te bereiden. |
IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
-
1978
- 1978-11-09 IT IT29653/78A patent/IT1192287B/it active
- 1978-11-10 GB GB7843984A patent/GB2010840B/en not_active Expired
- 1978-11-10 AT AT0807178A patent/AT369005B/de not_active IP Right Cessation
- 1978-11-10 FR FR7831898A patent/FR2411839B1/fr not_active Expired
- 1978-11-10 DK DK502078A patent/DK502078A/da not_active Application Discontinuation
- 1978-11-10 DE DE19782848912 patent/DE2848912A1/de active Granted
- 1978-11-10 CA CA000316120A patent/CA1120923A/fr not_active Expired
- 1978-11-10 SE SE7811637A patent/SE7811637L/xx unknown
- 1978-11-13 AU AU41546/78A patent/AU523346B2/en not_active Expired
- 1978-11-13 CH CH1166778A patent/CH645904A5/de not_active IP Right Cessation
- 1978-11-13 HU HU78FU368A patent/HU183008B/hu unknown
- 1978-11-13 NL NL7811220A patent/NL7811220A/xx not_active Application Discontinuation
- 1978-11-13 HU HU80281A patent/HU182098B/hu unknown
- 1978-11-13 ES ES475035A patent/ES475035A1/es not_active Expired
- 1978-11-14 JP JP14028678A patent/JPS5492987A/ja active Granted
-
1979
- 1979-03-26 FR FR7907572A patent/FR2413369A1/fr active Granted
- 1979-04-24 US US06/032,778 patent/US4267176A/en not_active Expired - Lifetime
- 1979-10-16 ES ES485066A patent/ES485066A1/es not_active Expired
- 1979-10-16 ES ES485068A patent/ES485068A1/es not_active Expired
- 1979-10-16 ES ES485065A patent/ES485065A1/es not_active Expired
- 1979-10-16 ES ES485067A patent/ES485067A1/es not_active Expired
-
1980
- 1980-12-05 US US06/213,684 patent/US4395411A/en not_active Expired - Lifetime
-
1984
- 1984-01-23 SE SE8400332A patent/SE8400332L/xx not_active Application Discontinuation
-
1985
- 1985-09-19 US US06/777,867 patent/US4596869A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4596869A (en) | 1986-06-24 |
DE2848912A1 (de) | 1979-05-17 |
AT369005B (de) | 1982-11-25 |
AU4154678A (en) | 1979-05-24 |
HU182098B (en) | 1983-12-28 |
US4267176A (en) | 1981-05-12 |
CH645904A5 (de) | 1984-10-31 |
ES485067A1 (es) | 1980-06-16 |
HU183008B (en) | 1984-04-28 |
IT1192287B (it) | 1988-03-31 |
DE2848912C2 (fr) | 1990-10-04 |
FR2413369A1 (fr) | 1979-07-27 |
SE8400332D0 (sv) | 1984-01-23 |
ES485066A1 (es) | 1980-06-16 |
SE8400332L (sv) | 1984-01-23 |
ES485065A1 (es) | 1980-06-16 |
FR2411839B1 (fr) | 1985-09-27 |
GB2010840A (en) | 1979-07-04 |
ATA807178A (de) | 1982-04-15 |
JPS6320832B2 (fr) | 1988-04-30 |
SE7811637L (sv) | 1979-05-15 |
JPS5492987A (en) | 1979-07-23 |
US4395411A (en) | 1983-07-26 |
CA1120923A (fr) | 1982-03-30 |
AU523346B2 (en) | 1982-07-22 |
IT7829653A0 (it) | 1978-11-09 |
FR2413369B1 (fr) | 1984-04-06 |
ES475035A1 (es) | 1980-01-01 |
FR2411839A1 (fr) | 1979-07-13 |
ES485068A1 (es) | 1980-06-16 |
GB2010840B (en) | 1982-12-22 |
NL7811220A (nl) | 1979-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK151253C (da) | Analogifremgangsmaade til fremstilling af 2-benzylphthalazin-4-yleddikesyrederivater | |
DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
DK129578A (da) | Fremgangsmaade til fremstilling af oximderivater af 3-acetoxymethyl-7-aminothiazolylacetamidocephalosporansyre | |
DK539578A (da) | Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater | |
DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
DK502078A (da) | Frefmgangsmaade til fremstilling af cephalosporansyrederivater | |
DK531178A (da) | Fremgangsmaade til fremstilling af phenylglycinderivater | |
DK258078A (da) | Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater | |
DK196077A (da) | Fremgangsmaade til fremstilling af di-n-propyleddikesyre | |
DK286777A (da) | Fremgangsmade til fremstilling af penicillansyrederivater | |
DK396880A (da) | Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater | |
DK455877A (da) | Fremgangsmaade til fremstilling af phenyleddikesyrederivater | |
DK129678A (da) | Fremgangsmaade til fremstilling af oximderivater af 7-aminothiazolylacetamidocephalosporansyre | |
DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
DK470978A (da) | R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate | |
DK153489C (da) | Analogifremgangsmaade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater | |
DK152130C (da) | Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater | |
DK494978A (da) | Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater | |
DK150484C (da) | Analogifremgangsmaade til fremstilling af 4-amino-3-thiophencarboxylsyrederivater | |
DK284977A (da) | Fremgangsmade til fremstilling af cephemderivater | |
DK147197C (da) | Analogifremgangsmaade til fremstilling af 2-hydrazonopropionsyrederivater | |
DK153377A (da) | Fremgangsmade til fremstilling af cephemderivater | |
DK68978A (da) | Fremgangsmaade til fremstilling af oximderivater af 3-thiadiazolythiomethyl-7-aminothiazolylacetamidocephalosporansyre | |
DK520178A (da) | Fremgangsmaade til fremstilling af phenoxyalkanolamin-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |